Oaklins Germany exclusively advised the private shareholders of MEDIK Hospital Design Group on the sale to STERIS
The private shareholders of MEDIK Hospital Design Group have sold their shares to STERIS plc.
MEDIK is a well-established provider of premium modular glass wall systems for operating theatres, intensive care units and other clinical environments, with its MEDglas® solutions successfully installed in more than 54 countries.
After 14 years of independence and the creation of a globally recognized brand, the combination with STERIS marks the next strategic step. STERIS is one of the world’s leading healthcare and life science companies with a strong focus on infection prevention and a broad portfolio of reprocessing, sterilization and surgical solutions.
Together, MEDIK and STERIS will expand their offering for hospitals and ambulatory surgery centers worldwide. MEDIK’s solutions ideally complement STERIS’ existing portfolio, enabling the combined group to position itself as a leading provider of turnkey room solutions in surgical and IPT environments.
The MEDIK management team will actively support the next phase of growth. Customers and partners can continue to rely on the highest quality standards while new markets are opened and additional application areas for the MEDglas® technology are developed.
- Oaklins Germany exclusively advised the shareholders on the sale to STERIS. – Deal Team: Dr. Lutz Becker, Christian Jellentrup, Moritz Jaeger
- Legal sell side: Ulf Marhenke, Trustwork Legal
- Legal buy side: Volker Heidbuechel, Uwe Martin, Squire Patton Boggs